Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome).
Clark
David W J
DW
Correa-Nunes
Ana-Maria
AM
Edwards
I Ralph
IR
D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects*; D005260:Female; D005385:Fingers / Q000098:blood supply*; D006801:Humans; D007511:Ischemia / Q000139:chemically induced*; D008297:Male; D009025:Morpholines / Q000009:adverse effects*; D011928:Raynaud Disease / Q000139:chemically induced*; D000077593:Reboxetine
D018759:Adrenergic Uptake Inhibitors; D009025:Morpholines; D000077593:Reboxetine